# Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis

> **NCT02749799** · PHASE4 · COMPLETED · sponsor: **Primus Pharmaceuticals** · enrollment: 45 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** DFD-01 (betamethasone dipropionate) Spray, 0.05%

## Key facts

- **NCT ID:** NCT02749799
- **Lead sponsor:** Primus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-08
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02749799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02749799, "Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02749799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*